Northwest up 17% premarket

• Shares of Nothwest Biotherapeutics (OTCQB:NWBO) are poised for a gap up this morning. CEO Linda Powers is slated to present DCVax data at a cancer immunotherapy conference today at 2:45 pm ET.
• The company sparred recently with The Street's Adam Feuerstein over its disclosures regarding DCVax approval in Germany.
• Analysts expect the firm to post $2.9M in revenues this year.